VG 1177

Drug Profile

VG 1177

Alternative Names: APi 1177; VG-1177; VGV-X

Latest Information Update: 14 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Viral Genetics
  • Developer University of Utah; VG Life Sciences
  • Class Antiretrovirals; Peptides
  • Mechanism of Action Immunomodulators; Invariant chain inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Brain injuries; Epilepsy; HIV infections; Preeclampsia
  • Research Inflammatory bowel diseases

Most Recent Events

  • 02 Mar 2015 VG Life Sciences granted a composition of matter patent in USA
  • 29 Jan 2015 VG Life Sciences has patent protection for a method of treating inflammatory bowel disease through the administration of a CLIP-inducing agent in USA
  • 29 Jan 2015 Early research in Inflammatory bowel disease in USA (unspecified route) before January 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top